Cargando…
Dual Therapy Appears Superior to Monotherapy for Low-Income Individuals With Newly Diagnosed Type 2 Diabetes
Background: There are variable recommendations regarding initiating monotherapy or dual therapy in patients with newly diagnosed type 2 diabetes (T2D). Clear initial strategies are of particular importance in underserved settings where access to care and financial burdens are significant barriers. O...
Autores principales: | Vaughan, Elizabeth M., Johnston, Craig A., Hyman, David J., Hernandez, Daphne C., Hemmige, Vagish, Foreyt, John P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748290/ https://www.ncbi.nlm.nih.gov/pubmed/29216790 http://dx.doi.org/10.1177/2150131917745760 |
Ejemplares similares
-
Lamotrigine monotherapy for newly diagnosed typical absence seizures in children()
por: Holmes, Gregory L., et al.
Publicado: (2008) -
Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
por: Zhao, Fen, et al.
Publicado: (2023) -
Pulmonary Infection in a Patient After Stem Cell Transplantation
por: Dandachi, Dima, et al.
Publicado: (2017) -
Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy
por: Lindauer, Andreas, et al.
Publicado: (2017) -
Efficacy and tolerability of eslicarbazepine acetate as monotherapy in patients of newly diagnosed focal epilepsy
por: Saxena, S., et al.
Publicado: (2021)